Suppr超能文献

外周血中绝对淋巴细胞/单核细胞比值与霍奇金淋巴瘤 interim PET/CT 结果的联合预后价值

Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma.

作者信息

Simon Zsofia, Barna S, Miltenyi Z, Husi K, Magyari F, Jona A, Garai I, Nagy Z, Ujj G, Szerafin L, Illes A

出版信息

Int J Hematol. 2016 Jan;103(1):63-9. doi: 10.1007/s12185-015-1884-z.

Abstract

Decreased absolute lymphocyte/monocyte ratio (LMR) in peripheral blood has been reported as an unfavorable prognostic marker in Hodgkin lymphoma. We aimed to investigate whether combining LMR and interim PET/CT scan result (PET2) confers stronger prognostic value than PET2 alone. 121 HL patients were investigated. LMR was calculated from a blood sample taken at the time of diagnosis. PET2 was carried out after the second chemotherapy cycle. Survival was calculated using the Kaplan-Meier method and significance was determined by log-rank test. Effect of variants on survival results was examined using univariate and multivariate analyses. Best LMR cut-off value was determined by receiver operating characteristic (ROC) curve. Best LMR cut-off value was 2.11 in the case of our patients (LMR > 2.11: favorable, LMR ≤ 2.11: unfavorable). Overall and progression-free survivals (OS/PFS) were significantly worse both in lower LMR (≤ 2.11) (OS: P = 0.041, PFS: P = 0.044) and PET2 positive groups (OS: P < 0.001, PFS: P < 0.001). In PET2 positive patient group (n = 32) the low LMR result meant a significantly worse OS (0.030) and PFS (0.001). Both LMR and PET2 proved to be independent prognostic factors on multivariate analysis, and strengthened each other's effect.

摘要

外周血中绝对淋巴细胞/单核细胞比值(LMR)降低已被报道为霍奇金淋巴瘤的不良预后标志物。我们旨在研究将LMR与中期PET/CT扫描结果(PET2)相结合是否比单独使用PET2具有更强的预后价值。对121例HL患者进行了研究。LMR由诊断时采集的血样计算得出。PET2在第二个化疗周期后进行。采用Kaplan-Meier方法计算生存率,并通过对数秩检验确定显著性。使用单变量和多变量分析检查变量对生存结果的影响。通过受试者工作特征(ROC)曲线确定最佳LMR临界值。对于我们的患者,最佳LMR临界值为2.11(LMR>2.11:预后良好,LMR≤2.11:预后不良)。低LMR(≤2.11)组和PET2阳性组的总生存期和无进展生存期(OS/PFS)均显著较差(OS:P = 0.041,PFS:P = 0.044)以及(OS:P < 0.001,PFS:P < 0.001)。在PET2阳性患者组(n = 32)中,低LMR结果意味着OS(0.030)和PFS(0.001)显著更差。多变量分析显示,LMR和PET2均为独立的预后因素,且相互强化彼此的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验